Despite both studies not meeting their primary endpoints, there was a clear trend toward improved OS in favor of ICB.
← all excerpts
Rationale of Immunotherapy in Hepatocellular Carcinoma and Its Potential Biomarkers.
1
—
—
Despite both studies not meeting their primary endpoints, there was a clear trend toward improved OS in favor of ICB.